The Treasury consultation, Financing Growth in Innovative Firms - known more commonly as the Patient Capital Review - has now been published, and Chancellor Philip Hammond has urged "everyone with an interest… to respond".
The backdrop to the review is the gap between Britain's record in creating a fertile environment for start-up businesses and its performance helping those companies that are ready to take the next step and, it is hoped, become substantial commercial or industrial operations. Put simply, Britain puts a huge amount of effort into helping start-up businesses, with the result that this is an area in which the country possesses a global leading edge. High-net-worth individuals (HNWIs) and other private investors have been encouraged into start-ups by generous tax breaks. In terms of raisin...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes